Clinical trial
Treatment of Patients With Alcoholism and Attention Deficit Disorder
NCT00261872 · National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH · Completed
Key facts
| NCT number | NCT00261872 |
|---|---|
| Title | Treatment of Patients With Alcoholism and Attention Deficit Disorder |
| Official title | Treatment of Patients With Alcoholism and Attention Deficit Disorder |
| Lead sponsor | National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alcoholism, Attention Deficit Disorder |
| Intervention type | Drug |
| Interventions | Methylphenidate |
| Enrollment | 100 |
| Start date | Dec 1, 2005 |
| Completion | Apr 9, 2007 |
| First posted | Dec 5, 2005 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: